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Fear and aggression are among the most prominent behavioural problems in dogs. Oxytocin 19 
has been shown to play a role in regulating social behaviours in humans including fear and 20 
aggression. As intranasal oxytocin has been found to have some analogous effects in dogs and 21 
humans, here we investigated the effect of oxytocin on dogsʼ behaviour in the Threatening 22 
Approach Test. Dogs, after having received intranasal administration of oxytocin (OT) or 23 
placebo (PL), showed the same reaction to an unfamiliar experimenter, but OT pretreated 24 
dogs showed a less friendly first reaction compared to the PL group when the owner was 25 
approaching. Individual differences in aggression (measured via questionnaire) also 26 
modulated dogs’ first reaction. Moreover, subjects that received OT looked back more at the 27 
human (owner/experimenter) standing behind them during the threatening approach. These 28 
 2 
results suggest that oxytocin has an effect on dogsʼ response to the threatening cues of a 29 
human, but this effect is in interaction with other factors such as the identity of the 30 
approaching human and the ‘baseline’ aggression of the dogs. 31 
 32 
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Highlights 36 
Dogsʼ behaviour towards a threatening human is influenced by intranasal oxytocin. 37 
The familiarity of the threatening human (owner/experimenter) has a modulating role. 38 
Owner-rated aggression of the dogs affects their reaction to a threatening human. 39 
 40 
1. Introduction 41 
Dogs are the most commonly kept pets in the western world (Hart, 1995) and are present in 42 
almost every human society worldwide (Serpell, 2003). Thus dogs pose severe economical 43 
expenses to our societies not only through veterinary care and the pet food industry, but also 44 
because of problem behaviours. Aggression towards and fear from people are among the most 45 
commonly reported dog behavioural problems (Diesel et al., 2008; Stephen and Ledger, 2007; 46 
van der Borg et al., 1991), and the two are often interrelated (Guy et al., 2001; Klausz et al., 47 
2014; Landsberg et al., 2003; O’Sullivan et al., 2008). 48 
It is plausible to assume that oxytocin might have an effect on behaviours related to fear and 49 
aggression as this has already been shown in humans. Evidence suggests that oxytocin 50 
reduces fear responses to social stimuli in humans (Kirsch et al., 2005) through the 51 
attenuation of amygdala activation (Domes et al., 2007), that encourages social approach and 52 
affiliation. Thus the oxytocin induced reduction of social fear may have an impact on 53 
 3 
aggressive behaviour given the link between anxiety levels and aggression. Decreased levels 54 
of oxytocin in the cerebrospinal fluid of adult men and women have indeed been associated 55 
with higher levels of reported aggressive behaviour (Lee et al., 2009). Oxytocin is generally 56 
thought to promote positive behaviours (e.g. trust ‒ Kosfeld et al. 2005; Baumgartner et al. 57 
2008, and generosity ‒ Zak et al. 2007; Barraza et al. 2011) and thus is assumed to reduce 58 
agonistic behaviours. However, other studies have found that oxytocin can also increase 59 
aggression and competition, especially towards out-group members (De Dreu, 2012; De Dreu 60 
et al., 2010; Stallen et al., 2012) and it also might increase anxiety to unpredictable threat 61 
(Grillon et al., 2013). Importantly it has also been suggested that oxytocin can have 62 
differential effects according to subjectsʼ baseline level of aggressive responding (Alcorn et 63 
al., 2014). 64 
In case of dogs, however, relatively little is known about the effect of oxytocin on social 65 
behaviour. Recent research has found that polymorphisms in the oxytocin receptor (OXTR) 66 
gene are related to human directed social behaviours in dogs (Kis et al., 2014a) and that 67 
intranasally administered oxytocin promotes positive social behaviours toward both humans 68 
and conspecifics (Romero et al., 2014). It has also been reported that intranasally 69 
administered oxytocin induces positive expectations about ambivalent stimuli in dogs, 70 
especially in a social context (Kis et al., 2015), enhances dogsʼ use of human pointing 71 
gestures (Oliva et al., 2015), and increases gazing behaviour of female dogs to their owners in 72 
a neutral situation (Nagasawa et al., 2015). However, no study has yet investigated the effect 73 
of intranasal oxytocin on dogs’ behaviour in negatively valenced situations. 74 
Based on these previous results our aim in the current study was to investigate the effect of 75 
intranasal oxytocin on dogsʼ response to human behaviour cues of threat. In order to do that 76 
we applied the Threatening Approach Test (validated by Vas et al., 2008, 2005) previously 77 
used to test coping styles in police dogs (Horváth et al., 2007), aggression in shelter dogs (Kis 78 
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et al., 2014c) and to assess the dogs’ ability to use the owner as a secure base (Gácsi et al., 79 
2013). We also aimed to test the effect of group-belonging (familiarity of the interactants), 80 
thus dog were approached threateningly by both the owner (in-group partner) and an 81 
unfamiliar experimenter (out-group partner). Subjectsʼ baseline aggressiveness towards 82 
people was assessed by means of a questionnaire (Jones, 2008). 83 
 84 
2. Subjects and methods 85 
2.1. Ethical statement 86 
Research was done in accordance with the Hungarian regulations on animal experimentation 87 
and the Guidelines for the use of animals in research described by the Association for the 88 
Study Animal Behaviour (ASAB). Ethical approval was obtained from the National Animal 89 
Experimentation Ethics Committee (Ref No. XIV-I-001/531-4-2012). 90 
2.2. Subjects 91 
Thirty-six pet dogs (older than a year, mean age±SD: 4.7±2.6 years; 12 intact & 8 neutered 92 
males, 6 intact and 10 spayed females) from various breeds (16 mongrels and 20 purebreds 93 
from 14 different breeds: Belgian Shepherd, Black Russian Terrier, Border Collie, Boxer, 94 
Bulldog, Central Asian Shepherd Dog, Golden Retriever, Norwitch Terrier, Nova Scotia 95 
Duck Tolling Retriever, Schnauzer, Shipperke, Scottish Terrier, Siberian Husky, Stafforsihre 96 
Terrier) participated in the study. Subjects participated in two study occasions 1‒13 days apart 97 
receiving oxytocin and placebo pretreatments in a balanced order (N=18 dogs starting with 98 
each of the two treatments). On the first occasion the Threatening Approach Test (see later) 99 
was performed by an unfamiliar female experimenter (E), on the second occasion the same 100 
test was performed by the owner (O), 33 of the 36 owners were females. 101 
2.3. Pretreatment 102 
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The pretreatment was performed according to a protocol previously validated by confirming 103 
the physiological effect of oxytocin on electrocardiogram (ECG) measures (Kis et al., 2014b); 104 
please note that other studies (Nagasawa et al., 2015; Oliva et al., 2015) have used slightly 105 
different intranasal oxytocin administration methods. Subjects received 3 puffs, 12 IU 106 
(International Unit) oxytocin (Syntocinon, Novartis) or placebo (0.7% NaCl solution) in a 107 
within-subject design. Nasal spray was administered by an unfamiliar female (who had no 108 
other role in the experiment) while the dogs were gently held by the owner. This was 109 
followed by a 40 minute waiting period (that is presumed to be necessary for the central 110 
oxytocin levels to reach a plateau based on the vasopressin measurements of Born et al., 111 
2002). During this time dogs spent the first 30 minutes with an on-leash walk at the 112 
University Campus (avoiding any contact with other dogs or humans) during which the 113 
experimenter ensured that the owner did not make any social contact with the dog either (e.g. 114 
did not pet it, did not talk to it) and kept the length as well as the speed of the walk as 115 
standard as possible. Dogs spent the remaining 10 minutes resting in a quiet room with their 116 
passive owners present. During this last phase owners were asked to fill in an aggression 117 
questionnaire, the Aggression towards people scale form Jones (2008). The questionnaire 118 
(Table 1) consisted of six items and composed of one single factor (1‒5 scale). 119 
2.4. Behaviour testing 120 
Subjects participated in the Threatening Approach Test developed by Vas et al. (2005) (figure 121 
1.; supplementary video). During the first test occasion an unfamiliar female experimenter 122 
(one of three experimenters randomly selected for each dog) played the role of the 123 
approaching human while the owner stood motionless and silently 0.5 m behind the dog 124 
(‘Experimenter Approaching’ condition). During the second test occasion they switched their 125 
roles; the owner was the approaching human while the E was standing behind (‘Owner 126 
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Approaching’ condition). Owners received detailed instructions in order to behave in a way as 127 
similar to the experimenters as possible. 128 
Dogs were tethered on a 1.5 m long leash tied to a hook fixed to the floor. The approaching 129 
human (AH) entered the testing room and stood 3 m away from the dog and, if necessary, 130 
made some noise to get the dogʼs attention. When the dog looked at the AH, she/he began to 131 
approach it. The AH was moving slowly and haltingly (one step in every 4 s) with slightly 132 
bent upper body and she was looking steadily into the eyes of the dog without any verbal 133 
communication with the hands behind his/her back. 134 
The behaviour of the AH was determined and standardized across subjects according to the 135 
following ‘If ...then...’ rules: 136 
1) If the dog kept looking at the AH, then he/she continued to approach the dog 137 
until reaching the dog. 138 
2) If the dog interrupted the eye contact with the AH (moving away and/or turning 139 
head away), she/he stopped and waited motionless for about 4 s and then tried to 140 
attract the dogʼs attention by making some noise (e.g. coughing or scratching the 141 
ground with the foot). If the dog continued to avert its gaze the AH attempted to 142 
call the dog’s attention two more times (with 2 s in between attempts). Whenever 143 
the dog looked at her/him again, the AH continued the approach. If, however, the 144 
dog did not look at her/him after the third attempt, the Threatening Approach was 145 
terminated. 146 
3) If the dog showed active avoidance, that is, it moved away to the back of the 147 
owner/experimenter from the AH while keeping eye contact, she/he stopped and 148 
the Threatening Approach was terminated. 149 
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4) If the dog showed signs of aggression or fear, e.g. barked repeatedly or growled 150 
continuously (more than 4 s) and/or tried to attack the AH (moving ahead and 151 
stretching the leash), the Threatening Approach was terminated. 152 
After terminating the Threatening Approach the AH stepped back, crouched down and started 153 
calling the dog in a friendly voice. At the same time the dog was released and encouraged to 154 
go to the AH who petted it. 155 
2.5. Data analysis 156 
Behaviour coding was based on Vas et al. (2008, 2005). The First reaction of the subjects 157 
was coded on an ordinary scale from the moment of looking at the approaching human, until 158 
the end of the first step. Dogs received score 1 ‒ Friendly if they approached the human in a 159 
friendly way (with the tail wagging, ears up and no signs of aggression and/or fear), score 2 ‒ 160 
Approach if they approached or gazed at the human without tail wagging or wagging the tail 161 
between the legs and/or with the ears down, score 3 ‒ Neutral  if they behaved neutrally (e.g. 162 
standing still or sniffing around), score 4 ‒ Avoid if they avoided the human (retreating, 163 
stepping back) and score 5 ‒ Threatening if they moved towards the human in an unfriendly 164 
way (barking or growling without any signs of play ‒ e.g. play bow). 165 
Additionally the number of times the dog looked back at the human standing behind it was 166 
also coded. 167 
Inter-rater reliability was calculated by double coding of 10 dogs (28% of the sample) and 168 
resulted in a substantial agreement (0.61 ‒ 0.80 according to the categorization of Landis and 169 
Koch, 1977) for both First reaction (κ=0.73), and Looking back (κ=0.78). 170 
Generalized Linear Mixed Models were used to analyse the data with multinomial logistic in 171 
case of the First reaction variable, and negative binomial identity function in case of the 172 
Looking back variable. In case of both dependent variables we tested the main effect of two 173 
factors: pretreatment (OT/PL), identity of the approaching human (O/E), and one covariate: 174 
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aggression questionnaire score; as well as the two- and three-way interactions. In case of the 175 
First reaction variable two separate follow-up models (GLMMs) were run for the 176 
experimenter approaching and the owner approaching conditions. In case of the Looking back 177 
variable separate models could not be run (as only one placebo pretreated dog looked back at 178 
the experimenter when approached by the owner), thus we applied pairwise post hoc 179 
comparisons (SPSS 22 default option) in the original model in order to confirm the OT/PL 180 
effect. SPSS 22 was used for all data analysis. 181 
 182 
3. Results 183 
3.1. First reaction 184 
Dogs showed a Friendly first reaction in 32% of the cases, an Approach reaction in 25% of 185 
the cases, a Neutral reaction in 22% of the cases, an Avoid reaction in 10% of the cases and a 186 
Threatening reaction in 11% of the cases. The GLMM model showed no significant main 187 
effect of oxytocin/placebo (OT/PL) pretreatment (F=2.977, p=0.087) or identity of the human 188 
(O/E) approaching (F=0.673, p=0.413) on dogsʼ first reaction. The main effect of the 189 
questionnaire aggression score was, however, significant (F=4.049, p=0.046) with dogs that 190 
were rated more aggressive by their owner, receiving higher scores for their first reaction. 191 
Also there was a significant pretreatment (OT/PL) × identity (O/E) interaction (F=7.938, 192 
p=0.006; figure 2). The pretreatment (OT/PL) × questionnaire score (F=3.289, p=0.072) and 193 
the identity (O/E) × questionnaire score (F=0.088, p=0.767) interactions were non-significant. 194 
The three-way interaction (pretreatment × identity × questionnaire score) was significant 195 
(F=7.979, p=0.005; figure 3.). 196 
Our follow-up analysis showed that in case of the Experimenter Approaching condition there 197 
was no significant effect of OT/PL pretreatment (F=0.698, p=0.406) or questionnaire score 198 
(F=2.886, p=0.094, with a tendency for the questionnaire score to be positively related to the 199 
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first reaction score) and their interaction was also non-significant (F=0.627, p=0.431). In case 200 
of the Owner Approaching condition there was a significant OT/PL pretreatment effect 201 
(F=7.426, p=0.009) with OT pretreated dogs showing a less friendly first reaction. The main 202 
effect of the questionnaire score was not significant (F=1.130, p=0.293), but there was a 203 
significant pretreatment × questionnaire score interaction (F=7.550, p=0.008). 204 
 205 
3.2. Looking back at Human (Owner/Experimenter) 206 
The looking behaviour of dogs was influenced by both the pretreatment (OT/PL, F=5.007, 207 
p=0.029) and the identity of the human standing behind the dog during the threatening 208 
approach (O/E, F=6.152, p=0.016, figure 4). Pairwise post hoc analysis confirmed that OT 209 
pretreated dogs looked more at the human standing behind them compared to PL pretreated 210 
dogs (p<0.001), and dogs looked back more at their owner (i.e. when the experimenter was 211 
approaching) compared to the reversed condition (p<0.001). Dogsʼ baseline aggression 212 
(questionnaire score) had no effect (F=2.451, p=0.122) and all interactions were non-213 
significant (p>0.05). 214 
 215 
4. Discussion 216 
We have found evidence that oxytocin has the potential to modulate dogsʼ behaviour in a 217 
situation involving threatening behaviour signals by a human. Importantly, however this 218 
effect is in interaction with other factors such as the identity of the humans involved in the 219 
situation (owner or a stranger) and the baseline aggression of the dogs. This is in line with 220 
previous results (Kis et al., 2014a) showing that two OXTR polymorphisms (rs8679684 and 221 
19131AG) affect dogsʼ Friendliness, a behavioural score mainly composed of their reaction to 222 
a threatening stranger. Our results are also in line with human studies that indicate a 223 
modulating role of baseline aggression on the effect of oxytocin (Alcorn et al., 2014) and 224 
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others showing differential effects of oxytocin on conflict behaviour towards in-group versus 225 
out-group partners (De Dreu, 2012; De Dreu et al., 2010). However, as in our study dogs were 226 
tested in a fixed order (first in the Stranger Approaching and then in the Owner Approaching 227 
conditions) we cannot exclude the possibility of order effect (though previous research has 228 
shown that dogsʼ reaction in the Threatening Approach Test is consistent across test occasions 229 
except for immediate re-testing ‒ Klausz et al., 2014; Vas et al., 2008). 230 
Our results showed that contrary to our expectations oxytocin did not decrease aggressive 231 
responses in dogs, but they showed a less friendly first reaction towards their owners and 232 
behaved in the same way towards the experimenter as in the placebo group. This is in line 233 
with other recent research suggesting that oxytocin is not a magical “trust elixir” 234 
(Mikolajczak et al., 2010), and that despite increasing prosocial behaviours, it does not make 235 
people blind to negative social stimuli, but on the contrary in some cases it even increases the 236 
salience of negative social stimuli (Theodoridou et al., 2013). But because of these results the 237 
direct applied relevance of our findings is questionable, as a “desirable” outcome would be to 238 
use a treatment that decreases unwanted aggression. However in case of some working dogs 239 
(e.g. police dogs) sensitisation to threatening social stimuli might also be beneficial. 240 
Furthermore we find that dogs look back at the human (owner or experimenter) standing 241 
behind them during the threatening approach more often after oxytocin pretreatment. This 242 
finding is in line with the study of Guastella et al. (2008) showing that oxytocin increases 243 
looking towards the eye-region of faces in humans and corresponds with more recent studies 244 
(Nagasawa et al., 2015) demonstrating that dogs look more at their owners in a neutral 245 
situation after oxytocin administration. Note, however that in our previous study (Kis et al., 246 
2014a) we could not find any effect of OXTR polymorphisms on looking at humans during a 247 
problem-solving task in dogs. Thus in a more naturalistic situation when the owner is allowed 248 
to communicate with the dog when it looks back at him/her upon detecting a threat (see e.g. 249 
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Merola et al., 2013, 2011 for social referencing about threatening stimuli) this might make a 250 
difference in the controllability of their fear and/or aggression response.  251 
It is also important to note that clinical/veterinary practice may not benefit from the research 252 
findings on the behavioural effects of a single dose of intranasal oxytocin. Chronic oxytocin 253 
treatment has been for example proved to be less effective in improving the symptoms of 254 
young patients diagnosed with autism (Guastella et al., 2015) as it could have been expected 255 
based on the promising results of single-dose studies. 256 
In the present study oxytocin only influenced dogsʼ first reaction to the owner, but not to the 257 
experimenter. This might suggest that the effect of oxytocin is specific and/or more 258 
pronounced towards socially more relevant partners (see e.g. Kis et al., 2014b for the 259 
modulating role of social task context on the oxytocin effect in a cognitive bias task). An 260 
alternative explanation is that similarly to Alcorn et al. (2014), who found that human subjects 261 
with low levels of baseline aggressive behaviour showed an increase in aggressive behaviour, 262 
but subjects with high baseline aggressive responding did not, our data might merely reflect 263 
that the level of aggression towards the owner is lower than to the experimenter. 264 
In sum our results provide evidence for the effects of physiological (exogenous oxytocin) and 265 
contextual (owner/stranger) factors as well as individual differences (baseline aggression) on 266 
dogsʼ behaviour in the Threatening Approach Test. Clearly, these phenomena deserve further 267 
investigation in order to determine the possible applied relevance of these results as well as 268 
shed light on the role of other factors such as the gender of the approaching human or training 269 
history of the dogs. 270 
 271 
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Figure captions 379 
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Table 1. Items of the aggression questionnaire. Owners scored their dogs on a 1‒5 scale. 380 
Figure 1. Photograph showing the Threatening Approach Test 381 
Figure 2. First reaction of the dogs (until the first step of the approaching human) towards 382 
their owner and an unfamiliar experimenter after oxytocin or placebo pretreatment; median, 383 
quartiles, whiskers and outliers 384 
Figure 3. Relationship between dogsʼ baseline aggression (questionnaire score) and their first 385 
reaction to the approaching owner or experimenter after oxytocin and placebo pretreatment 386 
Figure 4. Frequency of looking back at the human (owner/experimenter) in the placebo and 387 
oxytocin pretreated groups in the Owner Approaching and Experimenter Approaching 388 
conditions; median, quartiles, whiskers and outliers 389 
 390 
Table 1. 391 
Questionnaire item Multiplier 
Dog behaves aggressively towards unfamiliar people. +1 
Dog is friendly towards unfamiliar people. -1 
Dog shows aggression when nervous or fearful. +1 
Dog behaves aggressively in response to perceived threats 
from people (e.g., being cornered, having collar reached for). 
+1 
Dog behaves aggressively when restrained or handled  
(e.g., groomed). 
+1 
 392 
